Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00653757 · ClinicalTrials.gov registry record · Phase 1
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
NCT00653757: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT00653757 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00653757, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Using scintigraphy to plan specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the side effects and best way to give intensity-modulated radiation therapy and to see how well it works in treating patients with stage I, stage II, stage III, or stage IV prostate cancer.
Interventions
- DRUG leuprolide acetate
- RADIATION intensity-modulated radiation therapy
- DRUG goserelin acetate
- RADIATION image-guided radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-03 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00653757
The ClinicalTrials.gov registry entry for NCT00653757 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which leuprolide acetate is the first listed.
NCT00653757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00653757 about?
NCT00653757 is a clinical study titled "Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Using scintigraphy to plan specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studyin...
What is the current status of trial NCT00653757?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2002-03. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00653757?
The interventions under investigation include: leuprolide acetate (DRUG), intensity-modulated radiation therapy (RADIATION), goserelin acetate (DRUG), image-guided radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00653757?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.